skip to content »

Translational Biology & Molecular Medicine

Houston, Texas

Benchtop, Research, Bedside and Application
Translational Biology & Molecular Medicine Graduate Program
not shown on screen

Ashok Balasubramanyam, M.D.

Department of Medicine - Diabetes, Endocrinology and Metabolism

Phone: 713-798-8654
Fax: 713-798-3810


  • M.D., St. John's Medical College, Bangalore, India
  • Residency, Baylor College of Medicine, Houston, TX
  • Fellowship, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Research Interests

  • Diabetes
  • Molecular pathology
  • Mouse models
  • Clinical trials

Selected Publications

  • Balasubramanyam A, Mersmann H, Jahoor F, Phillips T, Schubert U, Brar B, Iyer D, Smith EO, Takahashi H, Lu H, Kino T, Anderson PL, Henklein P, Kopp JB. Effects of transgenic expression of HIV-1 viral protein R (Vpr) on lipid and energy metabolism in mice. Am J Physiol Endocrinol Metab. 2007. 292:E40-8
  • Fareau GG, Maldonado M, Oral E, Balasubramanyam A. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome. Metabolism. 2007. 56(5):670-5.
  • Balasubramanyam A, Garza G, Rodriguez L, Hampe C, Gaur LK, Lernmark A, Maldonado M. Accuracy and predictive value of classification schemes for ketosis prone diabetes mellitus (KPDM). Diabetes Care. 2006. 29:2575-9.
  • Garcia JM, Iyer D, Poston WSC, Marcelli M, Reeves R, Foreyt J, Balasubramanyam A. Rise of plasma ghrelin with weight loss is not sustained during weight maintenance. Obesity. 2006. 14:1716-23.
  • Hampe C, Nalini R, Maldonado M, Hall T, Garza G, Iyer D, Balasubramanyam A. Association of amino-terminal-specific anti-glutamate decarboxylase (GAD65) autoantibodies with beta cell functional reserve and a milder clinical phenotype in patients with GAD65 antibodies and ketosis prone diabetes mellitus (KPDM). J Clin Endocrinol Metab. 2006. 92:462-7.
  • Samson SL, Pownall HJ, Scott LW, Ballantyne CM, Smith EO, Sekhar RV, Balasubramanyam A. Heart Positive: Design of a randomized controlled clinical trial of intensive lifestyle intervention, niacin and fenofibrate for HIV lipodystrophy/dyslipidemia. Contemporary Clinical Trials. 2006. 27:518-30.
  • Balasubramanyam A, Sekhar RV, Jahoor F, Jones PH, Pownall HJ. Pathophysiology of dyslipidemia and increased cardiovascular risk in HIV lipodystrophy: a model of 'systemic steatosis'. Curr Opin Lipidol. 2004. 15(1):59-67.

E-mail this page to a friend